Manteio Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Manteio Capital’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-57,586	Closed	-$73K	–	232
2021 Q4	$73K	Buy	+57,586	New	+$103K	0.09%	233

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Manteio Capital's SPPI Position: Q1 2022 in Review

Manteio Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 57,586 shares — an estimated $73K sold.

Manteio Capital first reported a position in SPPI in Q4 2021 and held it in 1 quarter. The position peaked at $73K in Q4 2021. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

Manteio Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Manteio Capital sold 57,586 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $73K.
Manteio Capital first reported a position in Spectrum Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Manteio Capital's Spectrum Pharmaceuticals Inc position peaked at $73K in Q4 2021.
101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Manteio Capital's 13F filing for Q1 2022.